It is not a finished drug and has zero standalone therapeutic relevance. Its sole purpose is process control—specifically selective protection of the N² position during multi-step synthesis. N²-Tritylolmesartan medoxomil is a protected, late-stage pharmaceutical intermediate used in the industrial synthesis of olmesartan medoxomil.
N2-Tritylolmesartan medoxomil
| API Name | Olmesartan |
|---|---|
| CAS No | 1020157-01-0 |
| Molecular Formula | C48H44N6O6 |
| Molecular Weight | 800.9 g/mol |
| Synonyms | (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate |
Zoho Contact Form
"*" indicates required fields